Antonella Meloni1, Massimiliano Missere2, Gennaro Restaino2, Laura Pistoia1, Vincenzo Positano1, Emanuele Grassedonio3, Nicolò Schicchi4, Giuseppe Peritore5, Francesco Massei6, Nicola Dello Iacono7, Angelica Barone8, and Alessia Pepe1
1MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy, 2Fondazione di Ricerca e Cura "Giovanni Paolo II", Campobasso, Italy, 3Policlinico "Paolo Giaccone", Palermo, Italy, 4Azienda Ospedaliero-Universitaria Ospedali Riuniti "Umberto I-Lancisi-Salesi", Ancona, Italy, 5"ARNAS" Civico, Di Cristina Benfratelli, Palermo, Italy, 6Azienda Ospedaliero Universitaria Pisana – Stabilimento S.Chiara, Pisa, Italy, 7Ospedale Casa Sollievo della Sofferenza IRCCSOspedale Casa Sollievo della Sofferenza IRCCS, San Giovanni Rotondo, Italy, 8Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
Synopsis
In patients with
hemoglobinopathies fat infiltration is a common finding and pancreatic volume
is significantly lower than in normal subjects but it is
not associated to age or gender. Pancreatic
iron overload is present in the 74% of the patients and it is associated with
reduced pancreatic volume. Patients with
diabetes have a lower pancreatic volume.
Introduction
We described the magnetic resonance imaging
(MRI) features of pancreas in patients with hemoglobinopathies, investigating
the association of pancreatic volume (PV) with pancreatic iron and diabetes.Methods
We considered 95 patients (44 F, mean age 38.81±8.83 years) consecutively
enrolled in the E-MIOT
(Extension-Myocardial Iron Overload in Thalassemia) project and 10 healthy
subjects.
All MRI examinations were performed with a 1.5T scanner. T2*
measurements were performed over pancreatic head, body and tail and global
value was the mean.1 PV was measured in non-gadolinium FSPGR T1-weighted in
phase and out of phase images in two different ways: including and excluding
the visible fat (PV-fat and PV-nofat, respectively). PV volume was normalized
by body surface area.Results
Due to complete fatty infiltration, pancreatic volume
was non analyzable in 9 patients, all females, all with pancreatic iron load
(global pancreas T2*<26 ms), and significantly older. So, we had a final
population of 86 patients.
In 17 patients there was visible fatty infiltration
and PV-fat was significantly higher than PV-no fat (33.85±17.44 cm3 vs 29.72±13.21
cm3/m2; P=0.001). PV was not associated to age or gender.
Mean pancreatic volume in healthy subjects was 46.28±9.19
cm3/m2, significantly higher than the value detected in the patients, both
including and excluding fat (P=0.002 and P<0.0001, respectively).
The 74.0% of the patients had pancreatic iron (global
pancreas T2*<26 ms). PV-fat was comparable between patients with and without
pancreatic iron, while PV-no fat was significantly lower
in patients with pancreatic iron (Figure 1).
The 7.0% of the patients had diabetes. PV-fat was
comparable between patients with and without pancreatic iron, while PV-nofat
was significantly lower in patients with pancreatic iron (Figure 2).Conclusions
Patients with hemoglobinopathies showed a reduced pancreatic
volume in comparison to the healthy population, also without the exclusion of
the infiltrate fat, a really common finding. Moreover, among patients PV was
more reduced in presence of pancreatic iron overload and diabetes.Acknowledgements
No acknowledgement found.References
1. Meloni A, De Marchi D, Positano V,
et al. Accurate estimate of
pancreatic T2* values: how to deal with fat infiltration. Abdom Imaging
2015;40(8):3129-3136.